It was found that celastrol not only induced immunogenic cell death (ICD), but also down-regulated PD-L1 expression in tumor cells, activated both dendritic cells and T cells, and interrupted the PD-1/PD-L1 pathway between T cells and tumor cells. The gene discussed is CD274; the disease is neoplasm.